Utama › Kanser Hati (Karsinoma Hepatoselular) › Pennsylvania › Philadelphia
Kajian klinikal Kanser Hati (Karsinoma Hepatoselular) di Philadelphia, PA
16 kajian untuk Kanser Hati (Karsinoma Hepatoselular) sedang mencari peserta di lokasi dalam dan sekitar Philadelphia (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #98, Philadelphia
National Liver Cancer Screening Trial
Mengambil pesertaFasa 4
- University of Pennsylvania, Philadelphia
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Mengambil pesertaFasa 3
- Research Site, Philadelphia
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Mengambil pesertaFasa 1/2
- Children's Hospital of Philadelphia, Philadelphia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- University of Pennsylvania, Perelman School of Medicine, Philadelphia
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Mengambil pesertaFasa 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi jauh
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi jauh
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- Thomas Jefferson University, Philadelphia
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Mengambil peserta
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Y-90 Treatment Response Using Transarterial Radioembolization
Mengambil pesertaFasa 2
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Mengambil pesertaFasa 1/2
- University of Pennsylvania, Philadelphia
Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma
Mengambil pesertaFasa 1/2
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Mengambil pesertaFasa 2
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
SBRT With Atezo/Bev for HCC
Mengambil pesertaFasa 1
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
Mengambil pesertaKajian pemerhatian
- Thomas Jefferson Hospital, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Mengambil pesertaFasa 4
- Albert Einstein Healthcare Network, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Philadelphia
Kajian Kanser Hati (Karsinoma Hepatoselular) di bandar lain
- Houston, TX31 kajian
- New York City, NY24 kajian
- Dallas, TX19 kajian
- Los Angeles, CA19 kajian
- Boston, MA18 kajian
- Cleveland, OH18 kajian
- Chicago, IL16 kajian
- Pittsburgh, PA15 kajian
- San Francisco, CA14 kajian
- Orange, CA14 kajian
- Jacksonville, FL14 kajian
- San Antonio, TX13 kajian
Kajian lain di Philadelphia
- Kanser (semua jenis)59 kajian
- Kanser Payudara56 kajian
- Kanser Paru-paru Bukan Sel Kecil51 kajian
- Kanser Metastatik46 kajian
- Kanser Prostat44 kajian
- Kanser Kolorektal44 kajian
- Kanser Ovari44 kajian
- Kanser Paru-paru36 kajian
- Leukemia Mieloid Akut34 kajian
- Kegagalan Jantung31 kajian
- Kanser Endometrium28 kajian
- Depresi26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.